Literature DB >> 11336346

In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases.

X Li1, X Deng, Z Huang.   

Abstract

PURPOSE: To quantitatively evaluate the correlations between the amount of initial burst release and the surface-associated protein, and between the onset time for the second burst release and the matrix polymer degradation.
METHODS: Human serum albumin (HSA) was microencapsulated in polylactide (PLA) and poly-dl-lactide-poly(ethylene glycol) (PELA) with PEG contents of 5, 10, 20, and 30%, respectively, using the solvent extraction procedure based on formation of double emulsion w/o/w. Microspheres with similar particle size (1.7-2.0 microm), similar protein entrapment (2.1-2.8%) but different surface-associated proteins (9.3-53.6%) were used to evaluate the in vitro matrix degradation and protein release profiles. Degradation was characterized by studying the intrinsic viscosity decrease, medium pH change, and weight loss of the microspheres.
RESULTS: The matrix degradation and protein release profiles were highly dependent on the polymer composition of the microspheres. Faster decreases in the intrinsic viscosity of recovered matrix polymer, the microspheres weight, and the pH of degradation medium, and earlier onsets for the break in intrinsic viscosity reduction and the mass loss were detected for PELA microspheres with higher PEG content. The hydration and swelling of microspheres matrix contributed greatly to the degradation of matrix polymer. The HSA release showed triphasic profile and involved two mechanisms for all the microsphere samples. Smaller amount of initial burst release, larger gradual release rate, and earlier onset for the second burst release were observed for HSA from matrix polymer with higher PEG content. The extent of the initial burst release was quantitatively related with the surface-associated protein. The second burst release of HSA was observed to occur within 1 week after the onset for mass loss, which was also the break in the intrinsic viscosity reduction rate.
CONCLUSION: Protein release profiles could be rationalized by optimizing the matrix polymer degradation and microsphere characteristics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336346     DOI: 10.1023/a:1011043230573

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres.

Authors:  X Li; Y Zhang; R Yan; W Jia; M Yuan; X Deng; Z Huang
Journal:  J Control Release       Date:  2000-07-31       Impact factor: 9.776

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.

Authors:  J K Li; N Wang; X S Wu
Journal:  J Pharm Sci       Date:  1997-08       Impact factor: 3.534

4.  Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens.

Authors:  X Li; X Deng; M Yuan; C Xiong; Z Huang; Y Zhang; W Jia
Journal:  Int J Pharm       Date:  1999-02-15       Impact factor: 5.875

5.  Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.

Authors:  T Uchida; S Goto; T P Foster
Journal:  J Pharm Pharmacol       Date:  1995-07       Impact factor: 3.765

6.  Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres.

Authors:  S Cohen; T Yoshioka; M Lucarelli; L H Hwang; R Langer
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

7.  Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens.

Authors:  X M Deng; X H Li; M L Yuan; C D Xiong; Z T Huang; W X Jia; Y H Zhang
Journal:  J Control Release       Date:  1999-03-29       Impact factor: 9.776

8.  Release of human serum albumin from poly(lactide-co-glycolide) microspheres.

Authors:  M S Hora; R K Rana; J H Nunberg; T R Tice; R M Gilley; M E Hudson
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

9.  In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.

Authors:  I Yamakawa; Y Tsushima; R Machida; S Watanabe
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

10.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

Authors:  L M Sanders; J S Kent; G I McRae; B H Vickery; T R Tice; D H Lewis
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

  10 in total
  5 in total

Review 1.  Microbubbles in ultrasound-triggered drug and gene delivery.

Authors:  Sophie Hernot; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

2.  Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice.

Authors:  Maha Fadel; Kawser Kassab; Doa Abdel Fadeel
Journal:  Lasers Med Sci       Date:  2010-03       Impact factor: 3.161

Review 3.  Nanoparticle Vaccines Against Infectious Diseases.

Authors:  Rashmirekha Pati; Maxim Shevtsov; Avinash Sonawane
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

4.  Effect of Process Parameters on the Initial Burst Release of Protein-Loaded Alginate Nanospheres.

Authors:  Farhana Yasmin; Xiongbiao Chen; B. Frank Eames
Journal:  J Funct Biomater       Date:  2019-09-16

Review 5.  Advancements in prophylactic and therapeutic nanovaccines.

Authors:  Prateek Bhardwaj; Eshant Bhatia; Shivam Sharma; Nadim Ahamad; Rinti Banerjee
Journal:  Acta Biomater       Date:  2020-04-05       Impact factor: 10.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.